Leinco Technologies

Anti-Human IL-2 (Clone 5334)

Product Code:
 
LEI-I-172
Product Group:
 
Primary Antibodies
Host Type:
 
Mouse
Antibody Isotype:
 
IgG1
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
5334
Regulatory Status:
 
RUO
Target Species:
 
Human
Applications:
  • Flow Cytometry
  • Immunocytochemistry (ICC)
  • Mass Cytometry (CyTOF)
  • Neutralisation
Shipping:
 
Ambient
Storage:
 
This lyophilized mon°Clonal antibody should be stored desiccated at -20 to -70?C. After reconstitution this mon°Clonal antibody can be stored at 2-8?C for one month. For long-term storage of the reconstituted antibody aseptically aliquot into working volumes and store at -20 to -70?C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
 

No additional charges, what you see is what you pay! *

CodeSizePrice
LEI-I-172-25ug25 ug£432.00
Quantity:
LEI-I-172-100ug100 ug£694.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: US.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Show All

Further Information

Conjugate/Tag/Label:
Purified No Carrier Protein
Format:
This purified antibody is 0.2 um filtered and lyophilized from phosphate buffered saline (PBS), pH 6.2 with 5% Trehalose with no carrier proteins or preservatives.
Formulation:
This purified antibody is 0.2 um filtered and lyophilized from phosphate buffered saline (PBS), pH 6.2 with 5% Trehalose with no carrier proteins or preservatives.
Immunogen:
Purified Recombinant Human IL-2 (Accession # NP_000577)
Long Description:
Interleukin-2 (IL-2) is a potent T-cell mitogenic cytokine1 that functions as a primary regulator of T cell homeostasis and has been considered a prime candidate immunotherapeutics, both for increasing T cell levels/function and for augmenting vaccine-elicited viral-specific T cell responses.2 IL-2 plays a key role in setting the balance between immunity and tolerance. This cytokine has a dual role as the regulator of the two main phases of the immune response (proliferative and suppressive).3 IL-2 also stimulates growth and differentiation of B cells, NK cells, LAK cells, monocytes, and oligodendrocytes.
Target:
IL-2

References

1. Schachter, J. et al. (2009) Cytotherapy 11: 206 2. Sodora, DL. et al. (2009) Curr HIV Res. 7: 83 3. Alcocer-Varela, J. et al. (2009) Autoimmun Rev. 9(1):34-9.